Delivery Order SPE2DB22D1106-SPE2DB24FEKN8
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract, valued at $1,645.62, is a firm fixed price delivery order for the pharmaceutical product WEGOVY 1 MG/0.5 ML PEN 0.5ML. The award has a period of performance through March 19, 2024 and does not utilize any set-aside designations. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery...
- This is a federal contract award from the Medical Supply Chain division of the U.S. Defense agency to Amerisourcebergen Drug Corp's Corporate Office division. The contract, valued at $1,097.08, is a delivery order to provide the pharmaceutical product WEGOVY 0.5 MG/0.5 ML PEN 0.5ML. The contract has a firm fixed price pricing type and an ultimate completion date of April 23, 2024. There is no set-aside designation for this award. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery...
- This federal contract award, valued at $2,327.72, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is a firm fixed price delivery order for the pharmaceutical product WEGOVY 0.5 MG/0.5 ML PEN 0.5ML. This award is part of Amerisourcebergen Drug Corp's larger indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00, to provide a comprehensive range of pharmaceutical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,228.50 fixed-price delivery order is for the drug WEGOVY 0.5 MG/0.5 ML PEN 0.5ML, with a period of performance through March 3, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The firm fixed price delivery order, valued at $3,598.68, is for the pharmaceutical product WEGOVY 2.4 MG/0.75 ML PEN 0.75ML. No set-aside designation was used for this contract. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA,...
- This federal contract award, valued at $1,722.42, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the medication WEGOVY 0.5 MG/0.5 ML PEN 0.5ML, with an ultimate completion date of April 23, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is a delivery order from the Defense Logistics Agency (DLA) for the pharmaceutical product WEGOVY 0.5 MG/0.5 ML PEN 0.5ML. The $1,097.08 firm fixed price contract has a completion date of March 5, 2024. Amerisourcebergen Drug Corp serves as a prime contractor to the DLA Troop Support Medical program, providing a range of pharmaceutical and medical products and services to U.S. Department of...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is a delivery order valued at $4,975.31 for the pharmaceutical product WEGOVY 1 MG/0.5 ML PEN 0.5ML. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the U.S. Department of Defense. This delivery order is part of a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp, valued up to $999,999,999.00, that serves as...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution company. The $3,291.24 firm fixed price delivery order is for the supply of the specialty drug WEGOVY 0.5 MG/0.5 ML PEN 0.5ML to DLA Troop Support Medical facilities supporting the Department of Defense. AmerisourceBergen Drug Corp holds an indefinite delivery contract (IDC) with DLA...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of the pharmaceutical product WEGOVY 0.5 MG/0.5 ML PEN 0.5ML. The award is a Delivery Order with a Firm Fixed Price of $2,171.78, with an ultimate completion date of April 23, 2024. The contracting agency is the Defense Logistics Agency (DLA), which is a defense agency supporting the U.S. Armed Forces and other government agencies. Amerisourcebergen holds a larger Indefinite Delivery...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB24FEKN8Delivery Order
This federal contract award, valued at $1,545.78, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The award is for the delivery of the pharmaceutical product WEGOVY 0.5 MG/0.5 ML PEN 0.5ML, with a performance period through April 10, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary contract vehicle for the company to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. This specific award appears to be a firm fixed price delivery order issued under that IDC. No set-aside designation was used for this contract.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 4/9/24 |